1. Home
  2. TCPC vs RXST Comparison

TCPC vs RXST Comparison

Compare TCPC & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock TCP Capital Corp.

TCPC

BlackRock TCP Capital Corp.

HOLD

Current Price

$3.25

Market Cap

280.2M

Sector

Finance

ML Signal

HOLD

Logo RxSight Inc.

RXST

RxSight Inc.

HOLD

Current Price

$6.02

Market Cap

232.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCPC
RXST
Founded
2006
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
280.2M
232.2M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
TCPC
RXST
Price
$3.25
$6.02
Analyst Decision
Sell
Hold
Analyst Count
2
10
Target Price
$3.50
$9.78
AVG Volume (30 Days)
654.0K
1.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
18.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$134,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.08
$4.48
52 Week High
$7.41
$13.22

Technical Indicators

Market Signals
Indicator
TCPC
RXST
Relative Strength Index (RSI) 45.39 61.37
Support Level $3.10 $5.90
Resistance Level $3.54 $6.53
Average True Range (ATR) 0.10 0.38
MACD 0.02 0.06
Stochastic Oscillator 51.92 96.23

Price Performance

Historical Comparison
TCPC
RXST

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve its investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights, or direct equity investments.

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.

Share on Social Networks: